Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La.
about
Expression and DNA binding of the human 52 kDa Ro/SSA autoantigenProtein heterogeneity in the human Ro/SSA ribonucleoproteins. The 52- and 60-kD Ro/SSA autoantigens are encoded by separate genesThe mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphismsPathophysiology of cutaneous lupus erythematosusAntibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance.Clinical and serological features of patients with autoantibodies to GW/P bodies.Autoantibodies in the sicca syndrome (primary Sjögren's syndrome)Identification of a subset of patients with scleroderma with severe pulmonary and vascular disease by the presence of autoantibodies to centromere and histoneAntibodies targeting extractable nuclear antigens: historical development and current knowledge.Anti-Ro(SSA) autoantibodies are associated with T cell receptor beta genes in systemic lupus erythematosus patients.HLA-DQ gene complementation and other histocompatibility relationships in man with the anti-Ro/SSA autoantibody response of systemic lupus erythematosus.Implications of anti-Ro/Sjögren's syndrome A antigen autoantibody in normal sera for autoimmunity.Heterogeneity of the Ro/SSA antigen. Different molecular forms in lymphocytes and red blood cells.Association of an RNA polymerase III transcription factor with a ribonucleoprotein complex recognized by autoimmune sera.Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritisCerebral systemic lupus erythematosus.Respiratory disease in systemic lupus erythematosus: correlation with results of laboratory tests and histological appearance of muscle biopsy specimens.Interaction between VA RNA and the lupus antigen La: formation of a ribonucleoprotein particle in vitroThe Ro/SSA autoantigen as an immunogen. Some anti-Ro/SSA antibody binds IgG.Enhanced membrane expression of the 52 kDa Ro(SS-A) and La(SS-B) antigens by human keratinocytes induced by TNF alphaCharacterization and purification of lupus antigen La, and RNA-binding protein.Epitope spreading induced by immunization with synthetic SSB peptidesGenetics of clinical expression in SLE.Dermatologic overview of lupus erythematosus and its subsets.Anti-SSA/Ro antibody determination by enzyme-linked immunosorbent assay as a supplement to standard immunofluorescence in antinuclear antibody screening.Anti-Ro autoantibody with cross-reactive binding to the heavy chain of immunoglobulin G.Autoantibody profile in African-American patients with lupus nephritis.Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients.Serological markers in Arabs with lupus nephritis.Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus
P2860
Q24310807-2282593F-D912-433A-9B70-C8E38BA8EEA6Q24594978-F8EB18B3-DFE4-466B-848C-A81583FF7C63Q24671851-7390D336-481A-42BA-8AAA-C9C3A1667333Q26800275-8EA727C6-5530-4593-94CE-412AC04CE1C0Q28366910-E0DC6B7E-FB58-489B-9C48-854013055B8AQ33299144-0C4912C6-6AAE-4124-B9D4-E8EB0E9B70BAQ33555318-E8F26F90-5966-4894-A0AE-DF0ED22EDCEAQ33565885-EBDE1043-DACF-4967-A686-A769E60FA0ADQ34119034-0F0462F0-0350-4C51-A0E5-84B2ECAA96ECQ34239236-07A3CC20-57DD-4012-A77C-32C949A96391Q34259159-99E1852C-BFD3-4F3A-BDB4-727FF83DC181Q34564413-CB6B12D9-B36F-4618-B826-D267A681E0EAQ34570777-92BF3D74-13B8-4BAB-95C5-C539F1A9D8CBQ35274102-A47A9E00-01C8-486F-B054-3016F8ED9C37Q35552732-9DAC2C1E-B917-475B-99D0-AFC2B4E76518Q35604701-7CB46C36-1016-45F2-A482-FD46BB17EDBBQ36269545-362EB81E-DCAA-4703-8016-E8BF691CBC1BQ36319958-A965ACAD-344A-4B94-871B-CDBA43CE738AQ36353251-A7C0ABA3-41E5-4F59-82D1-D606EC87E4FDQ36671703-9DE027E8-7310-4F35-9C3A-E76E133CDD71Q36886690-6214EE6E-ADDE-4186-B664-A08EC8F14031Q37001022-E12BCE65-E464-4EAE-9271-F8984CCBF382Q37030643-8939BEE8-17BB-4109-B116-5F40041796BEQ38775028-1AAD5D2F-E5C1-4B72-8E62-D2DAE988877CQ40874909-723728A7-B145-45C9-9A20-A4F5A45BBDA7Q41552309-46F75915-6A54-4663-95CA-CD7A7420F551Q46768316-6D7448B9-CE20-4376-86F2-BDCECD3998A2Q46974758-D0654D8F-5187-43ED-9E3C-0595B3C19805Q48024795-2710776C-3BCF-48D1-B664-F6A2AF7DBDCFQ59034615-4E7F2354-1073-4F25-97BD-B0580FA37D55
P2860
Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Clinical and serological diffe ...... with antibodies to Ro and La.
@en
type
label
Clinical and serological diffe ...... with antibodies to Ro and La.
@en
prefLabel
Clinical and serological diffe ...... with antibodies to Ro and La.
@en
P2860
P356
P1476
Clinical and serological diffe ...... with antibodies to Ro and La.
@en
P2093
C A Wasicek
M Reichlin
P2860
P304
P356
10.1172/JCI110523
P407
P577
1982-04-01T00:00:00Z